A
Abeona Therapeutics Inc. (ABEO)
NCM – Real Time Price. Currency in USD
5.61
+0.05 (0.90%)
At close: Jun 26, 2026, 4:00 PM EDT
5.60
-0.01 (-0.15%)
After-hours: Jun 26, 2026, 6:02 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
5.61
+0.05 (0.90%)
At close: Jun 26, 2026, 4:00 PM EDT
5.60
-0.01 (-0.15%)
After-hours: Jun 26, 2026, 6:02 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $61.4M significantly exceed its total debt $23.2M, ensuring strong financial flexibility
Total current assets $183.0M exceed Total current liabilities $31.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-27.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$20.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.89 | 6.05 | 10 | |
| Quick ratio | 5.70 | 5.63 | 10 | |
| Debt to Equity | 0.16 | 0.30 | 9.0 | |
| Debt to Assets | 0.12 | 1.04 | 8.0 | |
| Interest coverage | -27.75 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1M | 4M | N/A | 6M | 15M |
| Gross Profit | -3M | 302K | -3M | -154K | 5M |
| Operating Income | -45M | -48M | -64M | -89M | -93M |
| Net Income | -40M | -54M | -64M | 71M | 66M |
| EBITDA | -41M | -45M | -61M | -86M | -89M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 2959.61 | -113.06 | 5.5 |
| Next quarter | N/A | -30 | 1.0 |
| Current year | 1039.06 | -171.45 | 5.5 |
| Next year | 110.63 | 90.99 | 10 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 60.89 | 16.54 | 16.67 | -8.54 | 7.3 |
| Y/Y | 999 | -41.94 | -24.99 | -4.72 | 3.3 |
| 3y average | 348.84 | 52.53 | 86.05 | -28.68 | 7.8 |
| 5y average | 184.74 | 42 | 67.58 | -28.11 | 7.8 |
| Weighted average score | 6.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |